• Info
  • Insider Ownership

Insider Trading & Ownership of Christopher B. Ehrlich

Location
San Francisco, CA
Signature
/s/ Andrew Kucharchuk, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Christopher B. Ehrlich and return when a new Insider Trading filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Quick Takeaways

  • Christopher B. Ehrlich has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CERO THERAPEUTICS HOLDINGS, INC. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Official SEC Source

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Christopher B. Ehrlich

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CERO, CEROW CERO THERAPEUTICS HOLDINGS, INC. Chairman and CEO, Director 07 Jan 2026
EFTR eFFECTOR Therapeutics, Inc. Director 13 Jun 2024
LPAA, LPAAU Launch One Acquisition Corp. Chief Executive Officer, Director 11 Jul 2024

Insider Transactions Reported by Christopher B. Ehrlich:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored